$3.32
▼ -0.6% Today
as of Aug 5, 16:52 ET
Last 30 days
Recent Press Releases & News
Nasus Pharma Appoints Pharmaceutical Industry Veteran Brendan P. O'Grady as Chief Executive Officer to Lead Strategic Growth
NSRX: NS002 June KOL Event
Nasus Pharma to Participate in the Zacks Life Sciences Investor Forum
Overview
52-week range
$1.98
$9.99
17% of range
Avg surprise (last 0)
—
Avg reaction (last 0)
—
Earnings trends
Implied volatility — last 90 days
No IV snapshots yet for NSRX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.